Boston Scientific Corp. XNYS: BSX

Expensive Performer

95.12 -0.13 (-0.14%)

6.6M XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Analyst Upgrade

Needham upgrades Boston Scientific to 'Buy' after acquiring a 90% stake in SoniVie for $540 million See details

Detailed Stock Analysis for Boston Scientific Corp. with Real-time Stock Report